147 related articles for article (PubMed ID: 22061641)
1. The discovery of novel cyclohexylamide CCR2 antagonists.
Lanter JC; Markotan TP; Zhang X; Subasinghe N; Kang FA; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Molloy CJ; Sui Z
Bioorg Med Chem Lett; 2011 Dec; 21(24):7496-501. PubMed ID: 22061641
[TBL] [Abstract][Full Text] [Related]
2. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.
Xue CB; Wang A; Meloni D; Zhang K; Kong L; Feng H; Glenn J; Huang T; Zhang Y; Cao G; Anand R; Zheng C; Xia M; Han Q; Robinson DJ; Storace L; Shao L; Li M; Brodmerkel CM; Covington M; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B
Bioorg Med Chem Lett; 2010 Dec; 20(24):7473-8. PubMed ID: 21036044
[TBL] [Abstract][Full Text] [Related]
3. Novel 2-aminooctahydrocyclopentalene-3a-carboxamides as potent CCR2 antagonists.
Cai C; Kang FA; Hou C; O'Neill JC; Opas E; McKenney S; Johnson D; Sui Z
Bioorg Med Chem Lett; 2013 Jan; 23(1):351-4. PubMed ID: 23182090
[TBL] [Abstract][Full Text] [Related]
4. The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity.
Cumming JG; Bower JF; Waterson D; Faull A; Poyser PJ; Turner P; McDermott B; Campbell AD; Hudson J; James M; Winter J; Wood C
Bioorg Med Chem Lett; 2012 Jun; 22(12):3895-9. PubMed ID: 22608963
[TBL] [Abstract][Full Text] [Related]
5. Discovery of potent, orally bioavailable small-molecule inhibitors of the human CCR2 receptor.
Doyon J; Coesemans E; Boeckx S; Buntinx M; Hermans B; Van Wauwe JP; Gilissen RA; De Groot AH; Corens D; Van Lommen G
ChemMedChem; 2008 Apr; 3(4):660-9. PubMed ID: 18188859
[TBL] [Abstract][Full Text] [Related]
6. QSAR studies on CCR2 antagonists with chiral sensitive hologram descriptors.
Nair PC; Srikanth K; Sobhia ME
Bioorg Med Chem Lett; 2008 Feb; 18(4):1323-30. PubMed ID: 18258426
[TBL] [Abstract][Full Text] [Related]
7. 4-Azetidinyl-1-heteroatom linked cyclohexane antagonists of CCR2: patent evaluation.
Horuk R; Guilford W
Expert Opin Ther Pat; 2011 Aug; 21(8):1275-80. PubMed ID: 21554155
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2).
Yang MG; Xiao Z; Shi Q; Cherney RJ; Tebben AJ; De Lucca GV; Santella JB; Mo R; Cvijic ME; Zhao Q; Barrish JC; Carter PH
Bioorg Med Chem Lett; 2012 Feb; 22(3):1384-7. PubMed ID: 22225639
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56(Lck) inhibitors.
Chen P; Norris D; Das J; Spergel SH; Wityak J; Leith L; Zhao R; Chen BC; Pitt S; Pang S; Shen DR; Zhang R; De Fex HF; Doweyko AM; McIntyre KW; Shuster DJ; Behnia K; Schieven GL; Barrish JC
Bioorg Med Chem Lett; 2004 Dec; 14(24):6061-6. PubMed ID: 15546730
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists.
Xia M; Hou C; DeMong DE; Pollack SR; Pan M; Brackley JA; Jain N; Gerchak C; Singer M; Malaviya R; Matheis M; Olini G; Cavender D; Wachter M
J Med Chem; 2007 Nov; 50(23):5561-3. PubMed ID: 17929797
[TBL] [Abstract][Full Text] [Related]
12. Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists.
Zhang X; Hufnagel H; Markotan T; Lanter J; Cai C; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Sui Z
Bioorg Med Chem Lett; 2011 Sep; 21(18):5577-82. PubMed ID: 21783361
[TBL] [Abstract][Full Text] [Related]
13. Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors.
Dyckman AJ; Li T; Pitt S; Zhang R; Shen DR; McIntyre KW; Gillooly KM; Shuster DJ; Doweyko AM; Sack JS; Kish K; Kiefer SE; Newitt JA; Zhang H; Marathe PH; McKinnon M; Barrish JC; Dodd JH; Schieven GL; Leftheris K
Bioorg Med Chem Lett; 2011 Aug; 21(15):4633-7. PubMed ID: 21705217
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core.
Shen DM; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Feeney WP; Jiang G; McCann ME; Mock S; Qureshi SA; Saperstein R; Shen X; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2011 Jan; 21(1):76-81. PubMed ID: 21147532
[TBL] [Abstract][Full Text] [Related]
15. Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents.
Bürli RW; Xu H; Zou X; Muller K; Golden J; Frohn M; Adlam M; Plant MH; Wong M; McElvain M; Regal K; Viswanadhan VN; Tagari P; Hungate R
Bioorg Med Chem Lett; 2006 Jul; 16(14):3713-8. PubMed ID: 16697190
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists.
Xia M; Hou C; Pollack S; Brackley J; DeMong D; Pan M; Singer M; Matheis M; Olini G; Cavender D; Wachter M
Bioorg Med Chem Lett; 2007 Nov; 17(21):5964-8. PubMed ID: 17869105
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in CCR2 antagonists.
Xia M; Sui Z
Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905
[TBL] [Abstract][Full Text] [Related]
19. Novel, orally bioavailable gamma-aminoamide CC chemokine receptor 2 (CCR2) antagonists.
Pasternak A; Marino D; Vicario PP; Ayala JM; Cascierri MA; Parsons W; Mills SG; Maccoss M; Yang L
J Med Chem; 2006 Aug; 49(16):4801-4. PubMed ID: 16884289
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
